Lonza's Visp, Switzerland location

Reuters: Lonza attempting buyout of Catalent

laptop against white background

As promised, we bring you the new and improved FiercePharma

China Satellite map

China promises to punish officials in vax supply chain lapse

Shire

Shire building $400M biologics plant, adding 400 jobs in Ireland

Shire, which operates out of the U.S. but has its domicile in Ireland for tax reasons, will build its first manufacturing facility in its adopted country.

Janssen's Prezista continuous manufacturing line

FDA urges companies to get on board with continuous manufacturing

Now that the FDA has for the first time approved a company switching production of a drug from batch to continuous manufacturing, the agency is inviting others…

Actavis facility in Iceland

Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug

Teva expects to close on its buyout of Allergan’s generic drug business, but for now, Allergan is responsible for the recall of more than 50 lots, consisting…

A Fresenius Kabi worker

Fresenius Kabi issues separate recalls for drugs made at Illinois plant

German generics unit Fresenius Kabi issued two separate voluntary recalls for injectables produced at its plant in Illinois.

Downtown Yantai, Shandong, China

South Korea’s Hanmi to spend $200M in China expansion

South Korea's Hanmi Science recently bought a swath of land near Yantai where it will spend about $200 million to build a manufacturing plant and R&D…

cough syrup on geometric table cloth

Pfizer recalls mislabeled bottles of adult Robitussin

Pfizer's Consumer Healthcare is pulling tens of thousands of bottles of one of its adult Robitussin products in the U.S. due to a labeling issue. It comes…

Eisai turns to PharmStandard for manufacturing in Russia

Despite a stumbling economy in recent years, Russia still holds a lot of appeal as an emerging market for drugmakers. Japan's Eisai is planning a major…

New player jumping into cell therapies manufacturing

With hundreds of cell and gene therapies percolating in clinics, a newly formed CDMO sees opportunity and says it's preparing to cash in on that with…

Indian pharma companies will face growing challenges in the U.S. as fewer big drugs will be losing their patents in the coming years with increased competition…

Teva is set to start manufacturing activities at a newly-expanded facility in Hungary following a HUF 2.3 billion ($8.4 million) project to bolster capacity…